Our host Anna Mohl speaks to Dr. Matt Henn, Ph.D, Chief Scientific Officer & Executive Vice President at Seres Therapeutics about understanding the microbiome. They’ll help us better understand how trillions of living organisms in our guts can affect everything from our digestion, to our mood, to how we fight off infections. Dr. Henn also talks about Seres’ work to develop what could potentially be the first approved pharmaceutical treatment based on the microbiome, and he gives us a glimpse of what’s on the horizon for innovations in the field.
This podcast is hosted by Nestle Health Science. This podcast represents the opinions of host Anna and her guests on the show and do not reflect the opinion of Nestle Health Science. The content is for informational purposes only and should not be taken as medical advice, please consult your healthcare professional for any medical questions.